Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).

Gumus, MahmutDane, FaysalKarabulut, BulentUygun, KazimAydin, KubraOrhan, BulentOksuzoglu, BernaTarhan, OktayBuyukberber, SuleymanOkutur, KeremYucel, IdrisZengin, NurullahIsikdogan, AbdurrahmanUnek, TugbaYavuz, SinanHarputluoglu, HakanOzen, Ridvan Seckin2019-10-272019-10-2720150732-183X1527-7755https://doi.org/10.1200/jco.2015.33.15_suppl.e14516https://hdl.handle.net/11454/42232Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, ILen10.1200/jco.2015.33.15_suppl.e14516info:eu-repo/semantics/closedAccessResults of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).Conference Object3315WOS:000358036902641Q1